H.E. Bredkjær

1.2k total citations
11 papers, 874 citations indexed

About

H.E. Bredkjær is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, H.E. Bredkjær has authored 11 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in H.E. Bredkjær's work include Ovarian function and disorders (5 papers), Reproductive Biology and Fertility (5 papers) and Neuropeptides and Animal Physiology (3 papers). H.E. Bredkjær is often cited by papers focused on Ovarian function and disorders (5 papers), Reproductive Biology and Fertility (5 papers) and Neuropeptides and Animal Physiology (3 papers). H.E. Bredkjær collaborates with scholars based in Denmark, Sweden and Germany. H.E. Bredkjær's co-authors include Peter Humaidan, Lars Westergaard, Claus Yding Andersen, Marie Louise Grøndahl, M. Bungum, Leif Bungum, Niels A. Hammer, Thomas van Overeem Hansen, Finn Cilius Nielsen and Ulla M. Wewer and has published in prestigious journals such as Human Reproduction, Fertility and Sterility and Reproduction.

In The Last Decade

H.E. Bredkjær

11 papers receiving 835 citations

Peers

H.E. Bredkjær
Ai Ai China
Tanya Timeva Bulgaria
Jing Fu China
Check Jh United States
Hwang Kwon South Korea
R.D. Salem United States
Ai Ai China
H.E. Bredkjær
Citations per year, relative to H.E. Bredkjær H.E. Bredkjær (= 1×) peers Ai Ai

Countries citing papers authored by H.E. Bredkjær

Since Specialization
Citations

This map shows the geographic impact of H.E. Bredkjær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.E. Bredkjær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.E. Bredkjær more than expected).

Fields of papers citing papers by H.E. Bredkjær

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.E. Bredkjær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.E. Bredkjær. The network helps show where H.E. Bredkjær may publish in the future.

Co-authorship network of co-authors of H.E. Bredkjær

This figure shows the co-authorship network connecting the top 25 collaborators of H.E. Bredkjær. A scholar is included among the top collaborators of H.E. Bredkjær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.E. Bredkjær. H.E. Bredkjær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Humaidan, Peter, H.E. Bredkjær, Lars Westergaard, & Claus Yding Andersen. (2009). 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertility and Sterility. 93(3). 847–854. 192 indexed citations
2.
Freiesleben, Nina la Cour, Kristine Løssl, Jeanette Bogstad, et al.. (2009). Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study. Human Reproduction. 24(10). 2523–2530. 10 indexed citations
3.
4.
Griesinger, Georg, Efstratios M. Κolibianakis, Evangelos Papanikolaou, et al.. (2007). Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertility and Sterility. 88(3). 616–621. 83 indexed citations
5.
Humaidan, Peter, H.E. Bredkjær, Leif Bungum, et al.. (2005). GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Human Reproduction. 20(5). 1213–1220. 363 indexed citations
6.
Hammer, Niels A., Thomas van Overeem Hansen, Anne Grete Byskov, et al.. (2005). Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. Reproduction. 130(2). 203–212. 118 indexed citations
7.
Bredkjær, H.E. & J. G. Grudzinskas. (2001). Cryobiology in human assisted reproductive technology. Would Hippocrates approve?. PubMed. 5(3). 211–3. 7 indexed citations
8.
Ottesen, Bent, H.E. Bredkjær, Eva Ekblad, et al.. (1995). Expression and characterization of preproVIP derived peptides in the human male urogenital tract. Neuropeptides. 28(4). 227–236. 8 indexed citations
9.
Bredkjær, H.E., Dorthe Rønnov‐Jessen, Lasse Fahrenkrug, Eva Ekblad, & Jan Fahrenkrug. (1991). Expression of preproVIP-derived peptides in the human gastrointestinal tract: a biochemical and immunocytochemical study. Regulatory Peptides. 33(2). 145–164. 17 indexed citations
10.
Palle, Connie, et al.. (1991). Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause. Maturitas. 13(4). 344–345. 5 indexed citations
11.
Palle, Connie, H.E. Bredkjær, Bent Ottesen, & Jan Fahrenkrug. (1990). VASOACTIVE INTESTINAL POLYPEPTIDE AND HUMAN VAGINAL BLOOD FLOW: COMPARISON BETWEEN TRANSVAGINAL AND INTRAVENOUS ADMINISTRATION. Clinical and Experimental Pharmacology and Physiology. 17(1). 61–68. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026